Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.38
BATS BZX Real-Time Price
As of 10:07am ET
 -0.24 / -4.27%
Today’s Change
5.02
Today|||52-Week Range
12.59
-31.90%
Year-to-Date

Today’s Trading

Previous close5.62
Today’s open5.61
Day’s range5.35 - 5.61
Volume19,427
Average volume (3 months)1,938,312
Market cap$706.3M
Dividend yield--
Data as of 10:07am ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.01-0.18%
ADROAduro Biotech Inc-0.17-1.55%
ZIOPZIOPHARM Oncology In...-0.20-3.47%
XNCRXencor Inc+0.39+2.11%
Data as of 10:08am ET, 06/30/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs